Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights Enbridge, U.S. Bank, HCA Healthcare, Hershey's and American International

Read MoreHide Full Article

For Immediate Release

Chicago, IL – March 10, 2023 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Enbridge Inc. (ENB - Free Report) , U.S. Bancorp (USB - Free Report) , HCA Healthcare, Inc. (HCA - Free Report) , The Hershey Company (HSY - Free Report) and American International Group, Inc. (AIG - Free Report) .

Here are highlights from Thursday’s Analyst Blog:

Top Stock Reports for Enbridge, U.S. Bancorp and HCA Healthcare

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Enbridge Inc., U.S. Bancorp and HCA Healthcare, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Enbridge have underperformed the Zacks Oil and Gas - Production and Pipelines industry over the past year (-13.6% vs. -4.6%). The company’s significant debt exposure is concerning.

ENB reported weak fourth-quarter results due to lower contributions from the Renewable Power Generation segment. Also, it has mostly been yielding lower dividends than the industry. As such, the stock warrants a cautious stance.

However, Enbridge has the longest and most sophisticated oil and liquids pipeline system in the world, which spreads across 17,809 miles. Hence, a significant portion of the midstream operator’s earnings is generated from transportation operations, driven by a string of long-term contracts.

ENB sanctioned C$8 billion of organic growth projects in 2022, bringing its total backlog to C$18 billion. The firm expects to put more than C$10 billion growth projects into service in 2024 and beyond. This is expected to generate significant EBITDA growth in the coming years.

(You can read the full research report on Enbridge here >>>)

Shares of U.S. Bancorp have underperformed the Zacks Banks - Major Regional industry over the past year (-14.2% vs. -9.6%). The company’s rising expenses might weigh on its bottom line in the upcoming quarters. Further, a concentrated loan portfolio and legal hassles are other key headwinds.

Nevertheless, U.S. Bancorp third-quarter results reflect a rise in revenues, supported by higher interest rates and margins. The bank has received all required regulatory approvals for the acquisition of MUFG Union Bank’s core regional banking franchise.

A solid business model and diverse revenue streams are likely to aid its financials. The company’s strong loan and deposit balances are positives. Its decent liquidity position is likely to support capital-deployment plans.

(You can read the full research report on U.S. Bankcorp here >>>)

HCA Healthcare’s shares have outperformed the Zacks Medical - Hospital industry over the past six months (+13.1% vs. +8.7%). The company’s revenues remain on an uptick on the back of a surge in admissions, outpatient surgeries and other procedures.

Multiple buyouts aided it in increasing patient volumes, enabled network expansion, added hospitals to its portfolio and boosted business scale. The company has been gaining from its telemedicine business line. As of Dec 31, 2022, it had $1.6 billion left under its buyback authorization.

However, the company's escalating operating expenses have been weighing on the margins. Declining cash flows indicates weaknesses in operations. As such, the stock warrants a cautious stance.

(You can read the full research report on HCA Healthcare here >>>)

Other noteworthy reports we are featuring today include The Hershey Company and American International Group, Inc.

Why Haven’t You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Published in